Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis
- Conditions
- Paraneoplastic Neurological SyndromeAutoimmune Encephalitis
- Registration Number
- NCT03957616
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
This study aims to provide an estimate of the incidence of paraneoplastic neurological syndromes and autoimmune encephalitides in France between the years 2016 and 2018. The study will describe the incidence of antibody subtypes and regional variations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- Clinical diagnosis of Paraneoplastic Neurological Syndrome (PNS) or Autoimmune Encephalitis (AE) made by the referring physician to the national center for PNS and AE in Lyon between 2016 and 2018
Read More
Exclusion Criteria
- Data on location of diagnosis missing
- Patients diagnosed out of the mainland French territory
- Patients for whom insufficient data was available
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and prevalence of diagnosed Paraneoplastic Neurological Syndromes (PNS) and Autoimmune Encephalitis (AE) between 2016 and 2018. 3 years Comparison between general population of the French counties and the cohort of PNS to calculate incidence and prevalence.
- Secondary Outcome Measures
Name Time Method Location (city) of diagnosis 1 hour Name of city where the diagnosis of Paraneoplastic Neurological Syndromes (PNS) or Autoimmune Encephalitis (AE) was made.
French general population of each counties 3 years Person years for each region
Trial Locations
- Locations (1)
Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes
🇫🇷Lyon, France